As successive variants have emerged, vaccine efficacy has declined such that protection against symptomatic infection by Omicron lineage strains is now less than 50% (ref. 5) due to the increasing immune evasion properties associated with large numbers of amino acid substitutions and deletions in the S protein compared to ancestral SARS-CoV-2 strains6–10. Here, PROS1 is linked to infection.